ERBB2 and breast carcinoma: For example, in HER-2-positive breast cancer, brain metastasis is more accelerated, with 25–50% of advanced-stage patients being affected (Bendell et al., 2003; Clayton et al., 2004; Yau et al., 2006; Lin et al., 2009; Olson et al., 2013).